Pexacerfont for Stress-induced Food Craving

Clinical trial NCT01656577 · TERMINATED

Trial details

NCT number: NCT01656577
Sponsor: National Institute on Drug Abuse (NIDA)
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed Placebo

Start date: 2012-06-01
Primary completion: 2015-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.